局部复发直肠癌的外科综合治疗策略_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 王自强 , 毕亮 , 邓祥兵

四川大学华西医院胃肠外科中心（成都 610041）;

Corresponding author：

王自强, Email: wangzqzyh@163.com

Keywords：

DOI：

10.7507/1007-9424.201710087

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 王自强, 毕亮, 邓祥兵. 局部复发直肠癌的外科综合治疗策略. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2017, 24(11): 1301-1305. doi: 10.7507/1007-9424.201710087 Copy

1.	São Julião GP, Habr-Gama A, Vailati BB, et al. New Strategies in rectal cancer. Surg Clin North Am, 2017, 97(3): 587-604.
2.	Enríquez-Navascués JM, Borda N, Lizerazu A, et al. Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol, 2011, 17(13): 1674-1684.
3.	Lopez-Kostner F, Fazio VW, Vignali A, et al. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum, 2001, 44(2): 173-178.
4.	Warrier SK, Heriot AG, Lynch AC. Surgery for locally recurrent rectal cancer: tips, tricks, and pitfalls. Clin Colon Rectal Surg, 2016, 29(2): 114-122.
5.	Pilipshen SJ, Heilweil M, Quan SH, et al. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer, 1984, 53(6): 1354-1362.
6.	Swedish Rectal Cancer Trial; Cedermark B, Dahlberg M, et al. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med, 1997, 336(14): 980-987.
7.	van den Brink M, Stiggelbout AM, van den Hout WB, et al. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol, 2004, 22(19): 3958-3964.
8.	Simillis C, Baird DL, Kontovounisios C, et al. A systematic review to assess resection margin status after abdominoperineal excision and pelvic exenteration for rectal cancer. Ann Surg, 2017, 265(2): 291-299.
9.	Wibe A, Syse A, Andersen E, et al. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum, 2004, 47(1): 48-58.
10.	Frasson M, Garcia-Granero E, Parajó A, et al. Rectal cancer threatening or affecting the prostatic plane: is partial prostatectomy oncologically adequate? Results of a multicentre retrospective study. Colorectal Dis, 2015, 17(8): 689-697.
11.	Suzuki K, Gunderson LL, Devine RM, et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer, 1995, 75(4): 939-952.
12.	Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg, 2003, 237(4): 502-508.
13.	Moore HG, Shoup M, Riedel E, et al. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum, 2004, 47(10): 1599-1606.
14.	Park JK, Kim YW, Hur H, et al. Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection. Langenbecks Arch Surg, 2009, 394(1): 71-77.
15.	中华人民共和国卫生和计划生育委员会医政医管局, 中华医学会肿瘤学会分会. 中国结直肠癌诊疗规范 (2015 版). 中华普通外科学文献 (电子版), 2015, 9(6): 506-523.
16.	Boyle KM, Sagar PM, Chalmers AG, et al. Surgery for locally recurrent rectal cancer. Dis Colon Rectum, 2005, 48(5): 929-937.
17.	Yamada K, Ishizawa T, Niwa K, et al. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg, 2001, 88(7): 988-993.
18.	Valentini V, Morganti AG, De Franco A, et al. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome. Cancer, 1999, 86(12): 2612-2624.
19.	Harris CA, Solomon MJ, Heriot AG, et al. The outcomes and patterns of treatment failure after surgery for locally recurrent rectal cancer. Ann Surg, 2016, 264(2): 323-329.
20.	Lee DJ, Sagar PM, Sadadcharam G, et al. Advances in surgical management for locally recurrent rectal cancer: how far have we come? World J Gastroenterol, 2017, 23(23): 4170-4180.
21.	Faneyte IF, Dresen RC, Edelbroek MA, et al. Pre-operative staging with positron emission tomography in patients with pelvic recurrence of rectal cancer. Dig Surg, 2008, 25(3): 202-207.
22.	Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg, 2013, 100(8): 1009-1014.
23.	PelvEx Collaborative. Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration. Ann Surg, 2017, [Epub ahead of print].
24.	Rausa E, Kelly ME, Bonavina L, et al. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer. Colorectal Dis, 2017, 19(5): 430-436.
25.	You YN, Skibber JM, Hu CY, et al. Impact of multimodal therapy in locally recurrent rectal cancer. Br J Surg, 2016, 103(6): 753-762.
26.	Holman FA, Bosman SJ, Haddock MG, et al. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: results of 565 patients of two major treatment centres. Eur J Surg Oncol, 2017, 43(1): 107-117.
27.	Valentini V, Morganti AG, Gambacorta MA, et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase Ⅱ study. Int J Radiat Oncol Biol Phys, 2006, 64(4): 1129-1139.
28.	Wallace HJ 3^rd, Willett CG, Shellito PC, et al. Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. J Surg Oncol, 1995, 60(2): 122-127.
29.	常文举, 许剑民. 周围脏器浸润性结直肠癌的外科治疗及其评价. 中国实用外科杂志, 2013, 33(1): 81-84.
30.	Yang TX, Morris DL, Chua TC. Pelvic exenteration for rectal cancer: a systematic review. Dis Colon Rectum, 2013, 56(4): 519-531.
31.	Bouchard P, Efron J. Management of recurrent rectal cancer. Ann Surg Oncol, 2010, 17(5): 1343-1356.
32.	Bhangu A, Ali SM, Brown G, et al. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Ann Surg, 2014, 259(2): 315-322.
33.	姜勇, 万远廉, 刘玉村, 等. 局部复发直肠癌 187 例手术疗效及预后因素分析. 中华胃肠外科杂志, 2011, 14(8): 582-585.
34.	Milne T, Solomon MJ, Lee P, et al. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer. Ann Surg, 2013, 258(6): 1007-1013.
35.	Milne T, Solomon MJ, Lee P, et al. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies. Dis Colon Rectum, 2014, 57(10): 1153-1161.
36.	Moriya Y, Akasu T, Fujita S, et al. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum, 2004, 47(12): 2047-2053.
37.	Guo Y, Chang E, Bozkurt M, et al. Factors affecting hospital length of stay following pelvic exenteration surgery. J Surg Oncol, 2017, [Epub ahead of print].
38.	王自强, 张元川, 邓祥兵, 等. 低位直肠癌行后盆腔脏器切除联合远端阴道及会阴体切除术后会阴重建的方式及体会. 中国普外基础与临床杂志, 2013, 20(11): 1228-1233.
39.	Schiltz B, Buchs NC, Penna M, et al. Biological mesh reconstruction of the pelvic floor following abdominoperineal excision for cancer: A review. World J Clin Oncol, 2017, 8(3): 249-254.
40.	Devulapalli C, Jia WAT, DiBiagio JR, et al. Primary versus flap closure of perineal defects following oncologic resection: a systematic review and meta-analysis. Plast Reconstr Surg, 2016, 137(5): 1602-1613.
41.	Mirnezami AH, Sagar PM. Surgery for recurrent rectal cancer: technical notes and management of complications. Tech Coloproctol, 2010, 14(3): 209-216.

1. São Julião GP, Habr-Gama A, Vailati BB, et al. New Strategies in rectal cancer. Surg Clin North Am, 2017, 97(3): 587-604.
2. Enríquez-Navascués JM, Borda N, Lizerazu A, et al. Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol, 2011, 17(13): 1674-1684.
3. Lopez-Kostner F, Fazio VW, Vignali A, et al. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum, 2001, 44(2): 173-178.
4. Warrier SK, Heriot AG, Lynch AC. Surgery for locally recurrent rectal cancer: tips, tricks, and pitfalls. Clin Colon Rectal Surg, 2016, 29(2): 114-122.
5. Pilipshen SJ, Heilweil M, Quan SH, et al. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer, 1984, 53(6): 1354-1362.
6. Swedish Rectal Cancer Trial; Cedermark B, Dahlberg M, et al. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med, 1997, 336(14): 980-987.
7. van den Brink M, Stiggelbout AM, van den Hout WB, et al. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol, 2004, 22(19): 3958-3964.
8. Simillis C, Baird DL, Kontovounisios C, et al. A systematic review to assess resection margin status after abdominoperineal excision and pelvic exenteration for rectal cancer. Ann Surg, 2017, 265(2): 291-299.
9. Wibe A, Syse A, Andersen E, et al. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum, 2004, 47(1): 48-58.
10. Frasson M, Garcia-Granero E, Parajó A, et al. Rectal cancer threatening or affecting the prostatic plane: is partial prostatectomy oncologically adequate? Results of a multicentre retrospective study. Colorectal Dis, 2015, 17(8): 689-697.
11. Suzuki K, Gunderson LL, Devine RM, et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer, 1995, 75(4): 939-952.
12. Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg, 2003, 237(4): 502-508.
13. Moore HG, Shoup M, Riedel E, et al. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum, 2004, 47(10): 1599-1606.
14. Park JK, Kim YW, Hur H, et al. Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection. Langenbecks Arch Surg, 2009, 394(1): 71-77.
15. 中华人民共和国卫生和计划生育委员会医政医管局, 中华医学会肿瘤学会分会. 中国结直肠癌诊疗规范 (2015 版). 中华普通外科学文献 (电子版), 2015, 9(6): 506-523.
16. Boyle KM, Sagar PM, Chalmers AG, et al. Surgery for locally recurrent rectal cancer. Dis Colon Rectum, 2005, 48(5): 929-937.
17. Yamada K, Ishizawa T, Niwa K, et al. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg, 2001, 88(7): 988-993.
18. Valentini V, Morganti AG, De Franco A, et al. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome. Cancer, 1999, 86(12): 2612-2624.
19. Harris CA, Solomon MJ, Heriot AG, et al. The outcomes and patterns of treatment failure after surgery for locally recurrent rectal cancer. Ann Surg, 2016, 264(2): 323-329.
20. Lee DJ, Sagar PM, Sadadcharam G, et al. Advances in surgical management for locally recurrent rectal cancer: how far have we come? World J Gastroenterol, 2017, 23(23): 4170-4180.
21. Faneyte IF, Dresen RC, Edelbroek MA, et al. Pre-operative staging with positron emission tomography in patients with pelvic recurrence of rectal cancer. Dig Surg, 2008, 25(3): 202-207.
22. Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg, 2013, 100(8): 1009-1014.
23. PelvEx Collaborative. Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration. Ann Surg, 2017, [Epub ahead of print].
24. Rausa E, Kelly ME, Bonavina L, et al. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer. Colorectal Dis, 2017, 19(5): 430-436.
25. You YN, Skibber JM, Hu CY, et al. Impact of multimodal therapy in locally recurrent rectal cancer. Br J Surg, 2016, 103(6): 753-762.
26. Holman FA, Bosman SJ, Haddock MG, et al. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: results of 565 patients of two major treatment centres. Eur J Surg Oncol, 2017, 43(1): 107-117.
27. Valentini V, Morganti AG, Gambacorta MA, et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase Ⅱ study. Int J Radiat Oncol Biol Phys, 2006, 64(4): 1129-1139.
28. Wallace HJ 3^rd, Willett CG, Shellito PC, et al. Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. J Surg Oncol, 1995, 60(2): 122-127.
29. 常文举, 许剑民. 周围脏器浸润性结直肠癌的外科治疗及其评价. 中国实用外科杂志, 2013, 33(1): 81-84.
30. Yang TX, Morris DL, Chua TC. Pelvic exenteration for rectal cancer: a systematic review. Dis Colon Rectum, 2013, 56(4): 519-531.
31. Bouchard P, Efron J. Management of recurrent rectal cancer. Ann Surg Oncol, 2010, 17(5): 1343-1356.
32. Bhangu A, Ali SM, Brown G, et al. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Ann Surg, 2014, 259(2): 315-322.
33. 姜勇, 万远廉, 刘玉村, 等. 局部复发直肠癌 187 例手术疗效及预后因素分析. 中华胃肠外科杂志, 2011, 14(8): 582-585.
34. Milne T, Solomon MJ, Lee P, et al. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer. Ann Surg, 2013, 258(6): 1007-1013.
35. Milne T, Solomon MJ, Lee P, et al. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies. Dis Colon Rectum, 2014, 57(10): 1153-1161.
36. Moriya Y, Akasu T, Fujita S, et al. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum, 2004, 47(12): 2047-2053.
37. Guo Y, Chang E, Bozkurt M, et al. Factors affecting hospital length of stay following pelvic exenteration surgery. J Surg Oncol, 2017, [Epub ahead of print].
38. 王自强, 张元川, 邓祥兵, 等. 低位直肠癌行后盆腔脏器切除联合远端阴道及会阴体切除术后会阴重建的方式及体会. 中国普外基础与临床杂志, 2013, 20(11): 1228-1233.
39. Schiltz B, Buchs NC, Penna M, et al. Biological mesh reconstruction of the pelvic floor following abdominoperineal excision for cancer: A review. World J Clin Oncol, 2017, 8(3): 249-254.
40. Devulapalli C, Jia WAT, DiBiagio JR, et al. Primary versus flap closure of perineal defects following oncologic resection: a systematic review and meta-analysis. Plast Reconstr Surg, 2016, 137(5): 1602-1613.
41. Mirnezami AH, Sagar PM. Surgery for recurrent rectal cancer: technical notes and management of complications. Tech Coloproctol, 2010, 14(3): 209-216.

Previous Article
精准医疗时代下对结直肠癌的分子分型与预后预测的展望
Next Article
Ⅳ期结直肠癌转移病灶的局部根治性与姑息性处理进展

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

局部复发直肠癌的外科综合治疗策略

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content